Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung Su

Showing results (351-360 of 394) with videos related to

Pageof 40
Sort By:
The Journal of Infectious Diseases|May 13, 2020
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing ChemotherapyWei-Yuan Chang, Yen-Cheng Chiu, Fang-Wei Chiu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2015
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibitionTung-Hung Su, Chung-Wai Shiau, Ping Jao, et al.
Alimentary Pharmacology & Therapeutics|November 13, 2021
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatmentChen-Hua Liu, Cheng-Yuan Peng, Wei-Yu Kao, et al.
Scientific Reports|June 10, 2020
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysisChen-Hua Liu, Cheng-Yuan Peng, Yu-Jen Fang, et al.
Journal of Clinical Medicine|August 28, 2025
Clinical Effectiveness and Safety of Reduced-Dose Prasugrel in Asian Patients: The PROMISE-TW RegistryYu-Chen Wang, Chiung-Ray Lu, Yi-Tzone Shiao, et al.
Frontiers in Cardiovascular Medicine|March 14, 2022
Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor MonotherapySheng-Wei Huang, Po-Wei Chen, Wen-Han Feng, et al.
ACS Applied Materials & Interfaces|October 11, 2019
Interface Interaction Behavior of Self-Terminated Oligomer Electrode Additives for a Ni-Rich Layer Cathode in Lithium-Ion Batteries: Voltage and Temperature EffectsFu-Ming Wang, Tibebu Alemu, Nan-Hung Yeh, et al.
Scientific Reports|July 2, 2015
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trialChen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Scientific Reports|October 16, 2015
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized TrialChen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Journal of Hepatology|October 5, 2024
Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infectionChen-Hua Liu, Pin-Nan Cheng, Yu-Jen Fang, et al.
Pageof 40

Showing results (351-360 of 394) with videos related to

Sort By:
Pageof 40
The Journal of Infectious Diseases|May 13, 2020
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing ChemotherapyWei-Yuan Chang, Yen-Cheng Chiu, Fang-Wei Chiu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2015
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibitionTung-Hung Su, Chung-Wai Shiau, Ping Jao, et al.
Alimentary Pharmacology & Therapeutics|November 13, 2021
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatmentChen-Hua Liu, Cheng-Yuan Peng, Wei-Yu Kao, et al.
Scientific Reports|June 10, 2020
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysisChen-Hua Liu, Cheng-Yuan Peng, Yu-Jen Fang, et al.
Journal of Clinical Medicine|August 28, 2025
Clinical Effectiveness and Safety of Reduced-Dose Prasugrel in Asian Patients: The PROMISE-TW RegistryYu-Chen Wang, Chiung-Ray Lu, Yi-Tzone Shiao, et al.
Frontiers in Cardiovascular Medicine|March 14, 2022
Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor MonotherapySheng-Wei Huang, Po-Wei Chen, Wen-Han Feng, et al.
ACS Applied Materials & Interfaces|October 11, 2019
Interface Interaction Behavior of Self-Terminated Oligomer Electrode Additives for a Ni-Rich Layer Cathode in Lithium-Ion Batteries: Voltage and Temperature EffectsFu-Ming Wang, Tibebu Alemu, Nan-Hung Yeh, et al.
Scientific Reports|July 2, 2015
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: a randomized trialChen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Scientific Reports|October 16, 2015
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized TrialChen-Hua Liu, Chung-Feng Huang, Chun-Jen Liu, et al.
Journal of Hepatology|October 5, 2024
Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infectionChen-Hua Liu, Pin-Nan Cheng, Yu-Jen Fang, et al.
Pageof 40